期刊文献+

Ipr1和GFP基因真核共表达穿梭质粒的构建及其在人肺癌细胞中的表达

Construction of Shuttle Plasmid for Co-expression of Ipr1 and GFP Genes in Human Lung Cancer Cells
原文传递
导出
摘要 目的构建胞内病原体抗性基因1(Ipr1)和绿色荧光蛋白(GFP)基因真核共表达穿梭质粒,并在人肺腺癌细胞A549中表达。方法采用PCR方法,分别从质粒pEGFP-C1-Ipr1和pEGFP-C1中扩增Ipr1和GFP基因,将GFP基因、分枝杆菌复制子OriM和Ipr1基因同时克隆入多启动子真核共表达载体pBudCE4.1中,构建pBud-GFP-OriM-Ipr1穿梭质粒,脂质体法转染A549细胞,荧光显微镜观察GFP的表达,免疫组化方法检测Ipr1蛋白的表达。结果酶切和测序分析表明,pBud-GFP-OriM-Ipr1真核共表达穿梭质粒构建正确。转染A549细胞后,荧光显微镜下可观察到转染细胞中有GFP表达,免疫组化法可检测到Ipr1蛋白的表达,且定位于细胞核内。结论已成功构建Ipr1和GFP基因真核共表达穿梭质粒,为进一步研究Ipr1抗结核的功能奠定了基础。 Objective To construct a shuttle plasmid for co-expression of intracellular pathogen resistance gene 1 (Iprl) and green fluorescent protein(GFP) gene in human lung cancer A549 cells. Methods Iprl and GFP genes were amplified from plasmids pEGFP-CI-Iprl and pEGFP-C1 by PCR respectively. The amplified Iprl and GFP genes as well as mycobaeterium replicon OriM were cloned into eukaryotic co-expression vector pBudCE4.1, and the constructed shuttle plasmid pBud-GFP-OriM-lprl was transfected to A549 cells in mediation of liposome. The expression of GFP was observed by fluorescent microscopy, and that of Iprl protein was determined by immnnohistochemical assay. Results Both restriction analysis and sequencing proved that shuttle plasmid pBudGFP-OriM-Iprl was constructed correctly. Expressed GFP was observed by fluorescent microscopy in transfected A549 cells. Immunohistochemical assay proved that Iprl protein was expressed in transfected A549 cells and located in cell nucleus. Conclusion A shuttle plasmid for eukaryotie co-expression of Iprl and GFP genes was successfully constructed, which laid a foundation of further study on function of Iprl against tuberculosis.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第5期464-467,共4页 Chinese Journal of Biologicals
基金 国家自然科学基金(30771922)
关键词 胞内病原体抗性基因1 绿色荧光蛋白 穿梭质粒 共表达 肺癌细胞 Intracellular pathogen resistance gene 1 (Iprl) Green fluorescent protein (GFP) Shuttle plasmid Co-expression Lung cancer cells
  • 相关文献

参考文献11

  • 1Young DB, Perkins MD, Duncan K, et al. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest, 2008, 118 (4): 1255-1265.
  • 2Pieters J. Entry and survival of pathogenic mycobacteria in macrophage. Microbes Infect, 2001, 3(3): 249-255.
  • 3Fremond CM, Yeremeev V, Nicolle DM, et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest, 2004, 114( 12): 1790-1799.
  • 4Kramnik I, Dietrich WF, Demant P, et al. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci, 2000, 97( 15 ): 8560-8565.
  • 5Pan H, Yah BS, Rojas M, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature, 2005, 434(7034): 767-772.
  • 6伊正君,朱道银,陈全,李俊明,曾伟.人颗粒溶素与小鼠单链IL-12真核共表达质粒的构建及其在RAW264.7细胞中的表达[J].中国人兽共患病杂志,2005,21(11):936-939. 被引量:9
  • 7徐蕾,何永林,李娜,王瑜伟,朱道银.结核分枝杆菌复活促进因子E的原核表达及纯化[J].中国生物制品学杂志,2007,20(4):252-255. 被引量:1
  • 8Takahashi K, Ezekowitz RA. The role of the mannose-binding lectin in innate immunity. Clin Infect Dis, 2005, 41 (Suppl7): S440-S444.
  • 9Quesniaux V, Fremond C, Jacobs M, et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect, 2004, 6( 10): 946-959.
  • 10Steams T. Green fluorescent protein: the green revolution. Curr Biol, 1995, 5(3): 262-264.

二级参考文献22

  • 1Yan-Qin Lu,Jin-Xiang Han,Peng Qi,Wei Xu,Yan-Hui Zu,Bo Zhu.Rapid quantification of hepatitis B virus DNA by real-time PCR using efficient TaqMan probe and extraction of virus DNA[J].World Journal of Gastroenterology,2006,12(45):7365-7370. 被引量:9
  • 2Kida Y, Kuwano K, Zhang Y, et al. Acholeplasma laidlawii up-regulates granulysin gene expression via transcription factor activator protein-1 in a human monocytic cell line, THP-1. Immunology[J]. 2001 ,104(3):324-332.
  • 3Kida Y, Shimizu T, Kuwano K. Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1. Immunology[J]. 2002,107(4):507-516.
  • 4Bryk R, Lima CD, Erdjument-Bromage H, et al. Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein [J]. Science. 2002,295(5557):1073-1077.
  • 5Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae[J].Nature Genetics, 2002, 32(1):97-105.
  • 6Lieschke GJ,Rao PK,Gately MK,et al.Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo[J].Nature Biotechnol,1997,15(1):35-40.
  • 7Howard AD, Zwilling BS. Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice[J].Clin Exp Immunol. 1998,113(3):443-449.
  • 8Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo[J].Eur J Immunol. 2002,32(6):1605-1613.
  • 9Janssen R, Kruisselbrink A, Hoogteijling L, et al. Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model[J].Immunology. 2001,102(4):441-449.
  • 10Cooper AM, Magram J, Ferrante J, et al. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis[J].J Exp Med. 1997,186(1):39-45.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部